Uploaded July 2024 | Updated November 2026, 3 hours ago
To study how compounds affect neuron signals in the human brain, researchers in the Bioscience and Biotechnology Division at Lawrence Livermore National Laboratory (LLNL) are using a platform called “brain-on-a-chip.” With this platform, researchers can pursue medical counter measures and therapeutics to combat drug addiction and better understand neurodegenerative diseases like ALS.
Learn more about this technology at: str.llnl.gov/2019-05/fischer.
LLNL-VIDEO-860632
To study how compounds affect neuron signals in the human brain, researchers in the Bioscience and Biotechnology Division at Lawrence Livermore National Laboratory (LLNL) are using a platform called “brain-on-a-chip.” With this platform, researchers can pursue medical counter measures and therapeutics to combat drug addiction and better understand neurodegenerative diseases like ALS.
Learn more about this technology at: str.llnl.gov/2019-05/fischer.
LLNL-VIDEO-860632










